Welltory, a consumer health app with 18 million users, has secured US$2 million in growth financing from Braavo Capital to expand Welltory Care, its service for people living with chronic conditions. The funding extends a long-term partnership between the two companies, which has included several million dollars in prior growth financing. The new capital will primarily support growth and recruitment for Welltory Care while the company funds research and product development from its own resources.
Long-Term Financing Supports a Growing Care Model
The latest financing marks another stage in Welltory's ongoing relationship with Braavo Capital. The funding provider has supplied several million dollars in growth financing over the course of the partnership, supporting Welltory's expansion into new products and markets. This continued backing reflects Braavo's confidence in Welltory's mission and its ability to scale specialized health services.
Funding Allocation and Company Strategy
Welltory funds research and product development from its own resources, while Braavo financing will primarily support growth and recruitment for Care. This separation allows the company to maintain independent control over clinical research and product direction. It also ensures that the new capital directly targets the operational needs of expanding specialized care groups.
Building Specialized Support Around Chronic Conditions
Welltory Care brings together people with similar conditions, physiological patterns, and daily limitations by combining peer strategies with personal data, research, and medical expertise. The company uses digital phenotyping to analyze wearable data and self-reported experiences, identifying people with similar profiles and building specialized support around their needs. This approach moves beyond products designed for average users and focuses on the specific realities of living with chronic illness.
Leadership Weighs In on the Need for Personalization
Veranika Zdanovich, CCO of Welltory, said most health products are built for the average user, but chronic conditions are not average experiences. She noted that with 18 million users, Welltory can bring together people whose physiology and daily limitations are unusually similar, then build research and tools around that group. Mark Loranger, CEO of Braavo Capital, described Welltory as a long-term partner and expressed pride in supporting work that can improve health for millions of people.
Early Energy Lab Results Show Strong Engagement
Three months ago, Welltory launched its first Energy Lab group with 100 people experiencing post-exertional malaise, commonly known as PEM. Strong engagement has led the company to plan an expansion to 500 participants, while clinical outcomes are being collected through an IRB-approved study. The early response suggests that users value a care environment tailored to their specific physiological and daily challenges.
Next Steps for Welltory Care
Over the next year, Welltory plans to launch Care groups for migraine, long COVID and chronic fatigue, and irritable bowel syndrome. The company intends to apply the same digital phenotyping approach to these conditions, creating cohorts of users with shared physiological patterns. This expansion will build on the recruitment and growth resources enabled by the new financing from Braavo Capital.
The US$2 million financing from Braavo Capital will help Welltory scale a care model built around shared physiology and lived experience rather than broad averages. With an existing base of 18 million users and early engagement in its Energy Lab group, the company is positioned to expand specialized support across multiple chronic conditions. The partnership highlights how targeted digital health approaches can move beyond generic wellness tools to address the needs of underserved patient communities.